Oxytocin attenuates stress-induced reinstatement of alcohol seeking behavior in male and female mice
The neuropeptide oxytocin (OXT) has emerged as a potential therapeutic intervention in the treatment of both alcohol use disorder (AUD) and stress-related psychiatric illnesses.
The present study evaluates the effects of systemically administered (intraperitoneal (i.p.)) OXT treatment on alcohol relapse-like behavior in male and female mice.
Adult male and female C57BL/6J mice were trained to lever respond in operant conditioning chambers for alcohol in daily self-administration sessions. Once lever responding and alcohol intake stabilized, mice were tested under extinction conditions for 14 days before reinstatement testing. All mice underwent stress-induced reinstatement testing using either predator odor (2,3,5-trimethyl-3-thiazoline (TMT)) or the α-2 adrenergic receptor agonist yohimbine. In study 1, mice were exposed to TMT for 15 min and then immediately placed into operant conditioning chambers to examine alcohol-seeking behavior under extinction conditions. At 30 min prior to test session, separate groups of mice were injected with vehicle or OXT (0.1, 0.5, 1 mg/kg). In study 2, mice were injected with yohimbine (0.3, 0.625 mg/kg) 1 h prior to reinstatement testing. At 30 min post-yohimbine injection, mice are injected (i.p.) with vehicle or OXT (1 mg/kg).
OXT attenuated alcohol-seeking behavior in a dose-related manner in male and female mice in response to acute challenge with a predator odor. Additionally, OXT administration produced a similar decrease in alcohol relapse-like behavior triggered by the pharmacological stressor yohimbine in both sexes.
Systemic oxytocin administration attenuates stress-induced reinstatement of alcohol seeking in male and female mice.
KeywordsOxytocin Alcohol Stress Relapse Self-administration Mouse
This study was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (U01 AA014095, U24 AA020929, P50 AA0107061, F31 AA026483) and VA Medical Research (I01BX000813).
Compliance with ethical standards
All experimental protocols were approved by the Medical University of South Carolina Institutional Animal Care and Use Committee and consistent with guidelines of the NIH Guide for the Care and Use of Laboratory Animals.
Conflict of interest
The authors declare that they do not have conflicts of interest.
- Bernheim A, Leong KC, Berini C, Reichel CM (2017) Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats. Pharmacol Biochem Behav 161:13–21. https://doi.org/10.1016/j.pbb.2017.08.012 CrossRefPubMedPubMedCentralGoogle Scholar
- Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, Boucher AA, McGregor IS (2010) Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol 15:448–463. https://doi.org/10.1111/j.1369-1600.2010.00247.x CrossRefPubMedGoogle Scholar
- Dabrowska J, Hazra R, Ahern TH, Guo JD, McDonald AJ, Mascagni F, Muller JF, Young LJ, Rainnie DG (2011) Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: implications for balancing stress and affect. Psychoneuroendocrinology 36:1312–1326. https://doi.org/10.1016/j.psyneuen.2011.03.003 CrossRefPubMedPubMedCentralGoogle Scholar
- Day HE, Masini CV, Campeau S (2004) The pattern of brain c-fos mRNA induced by a component of fox odor, 2,5-dihydro-2,4,5-trimethylthiazoline (TMT), in rats, suggests both systemic and processive stress characteristics. Brain Res 1025:139–151. https://doi.org/10.1016/j.brainres.2004.07.079 CrossRefPubMedGoogle Scholar
- Dumais KM, Alonso AG, Bredewold R, Veenema AH (2016) Role of the oxytocin system in amygdala subregions in the regulation of social interest in male and female rats. Neuroscience 330:138–149. https://doi.org/10.1016/j.neuroscience.2016.05.036 CrossRefPubMedPubMedCentralGoogle Scholar
- Hansson AC, Koopmann A, Uhrig S, Bühler S, Domi E, Kiessling E, Ciccocioppo R, Froemke RC, Grinevich V, Kiefer F, Sommer WH, Vollstädt-Klein S, Spanagel R (2018) Oxytocin reduces alcohol cue-reactivity in alcohol-dependent rats and humans. Neuropsychopharmacology 43:1235–1246. https://doi.org/10.1038/npp.2017.257 CrossRefPubMedGoogle Scholar
- Jurek B, Slattery DA, Hiraoka Y, Liu Y, Nishimori K, Aguilera G, Neumann ID, van den Burg EH (2015) Oxytocin regulates stress-induced Crf gene transcription through CREB-regulated transcription coactivator 3. J Neurosci 35:12248–12260. https://doi.org/10.1523/JNEUROSCI.1345-14.2015 CrossRefPubMedPubMedCentralGoogle Scholar
- Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, Leggio L, Averbeck BB (2018) Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol Psychiatry 23:115–122. https://doi.org/10.1038/mp.2017.27 CrossRefPubMedGoogle Scholar
- Peris J, MacFadyen K, Smith JA, de Kloet AD, Wang L, Krause EG (2017) Oxytocin receptors are expressed on dopamine and glutamate neurons in the mouse ventral tegmental area that project to nucleus accumbens and other mesolimbic targets. J Comp Neurol 525:1094–1108. https://doi.org/10.1002/cne.24116 CrossRefPubMedGoogle Scholar
- Peters S, Slattery DA, Uschold-Schmidt N, Reber SO, Neumann ID (2014) Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 42:225–236. https://doi.org/10.1016/j.psyneuen.2014.01.021 CrossRefPubMedGoogle Scholar
- Qi J, Yang JY, Wang F, Zhao YN, Song M, Wu CF (2009) Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 56:856–865. https://doi.org/10.1016/j.neuropharm.2009.01.010 CrossRefPubMedGoogle Scholar
- Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, Schechter LE, Rizzo S, Rahman Z, Rosenzweig-Lipson S (2006) Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology 185:218–225. https://doi.org/10.1007/s00213-005-0293-z CrossRefPubMedGoogle Scholar
- Tan Y, Singhal S, Hiller H, Harden S, Nguyen D, Colon-Perez C, Febo M, Wang L, Cahill K, de Kloet A, Frazier C, Krause E (2017) Optogenetic excitation of neurons in the prefrontal cortex that express oxytocin receptors eliminates preference for social novelty in male mice. Society for Neuroscience Abstract No 783.12, 2017Google Scholar
- Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36:1178–1186. https://doi.org/10.1038/npp.2010.253 CrossRefPubMedPubMedCentralGoogle Scholar
- Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD (2004) Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci 24:2974–2982. https://doi.org/10.1523/JNEUROSCI.3432-03.2004 CrossRefPubMedGoogle Scholar
- Zanos P, Georgiou P, Wright SR, Hourani SM, Kitchen I, Winsky-Sommerer R, Bailey A (2014) The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology 39:855–865. https://doi.org/10.1038/npp.2013.285 CrossRefPubMedGoogle Scholar